Arbutus presents ab-729 clinical data and ab-101 preclinical data at aasld - the liver meeting®

Hbsag and hbv dna remain at low levels with no evidence of clinical relapse up to 44 weeks after discontinuing ab-729 and na therapy
ABUS Ratings Summary
ABUS Quant Ranking